Abstract
We investigated the effect of intravenous infusions of the therapeutically available amino acid solutions Moripron and Morihepamin (Roussel Morishita, Osaka, Japan) on gallbladder contraction and cholecystokinin (CCK) release in healthy male volunteers. Plasma CCK levels were measured by radioimmunoassay, using the antibody OAL-656, which is specific for the aminoterminus of CCK-8 and thus recognizes biologically active forms of all CCKs. The volume of the gallbladder was calculated by ultrasonographic measurements. Intravenous infusion of Moripron at the rate of 3.33 ml/min for 60 min, caused gallbladder contraction, with a peak response of 31.3±8.6% of the fasting volume at 45–60 min, and a significant increase in plasma CCK concentration, from 1.8±0.2 pmol/l to a peak of 9.9±1.5 pmol/l, at 30–45 min. The maximum gallbladder contraction and the peak CCK release during the Moripron infusion were not significantly different from findings after a test meal. There was a close relationship between the peak plasma CCK concentration and the maximal gallbladder contraction during the administration of Moripron, and this agent, even when infused at the rate of 1.67 ml/min, significantly increased plasma CCK levels and gallbladder contraction. Intravenous infusion of Morihepamin had no significant influence on gallbladder volume or plasma CCK levels. The discrepancy in responses appeared to be related to differences in composition between Moripron and Morihepamin, and not to the total dose of amino acid. Intravenous infusions of amino acids appear to have different effects on gallbladder contraction and plasma CCK secretion depending on the amino acids composition. Our findings suggest that an intravenous infusion of Moripron could be used for the prophylaxis of acute acalculous cholecystitis and sludge formation due to reduced biliary motility in patients on total parenteral nutrition.
Similar content being viewed by others
References
Pitt HA, King W, Mann LL, et al. Increased risk of cholelithiasis with prolonged total parenteral nutrition. Am J Surg 1983; 145:106–111.
Roslyn JJ, Pitt HA, Mann LL, et al. Gallbladder disease in patients on long-term parenteral nutrition. Gastroenterology 1983;84:148–154.
Messing B, Bories C, Kunstlinger F, et al. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology 1986;84:1012–1019.
Cano N, Cicero F, Ranieri F, et al. Ultrasonographic study of gallbladder motility during total parenteral nutrition. Gastroenterology 1986;91:313–317.
Klein S, Nealon WH. Hepatobiliary abnormalities associated with total parenteral nutrition. Semin Liver Dis 1989;8:237–246.
Lilja P, Fagan CJ, Wiener J, et al. Infusion of pure cholecystokinin in humans. Gastroenterology 1982;83:256–261.
Doty JF, Pitt HA, Porter-Fink V, et al. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease. Ann Surg 1985;201:76–80.
Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parenteral nutrition-induced biliary sludge in humans. Surg Gynecol Obstet 1990;170:25–31.
Hasse C, Zielke A, Al-Bazaz B, et al. Influence of ceruletide on gallbladder contraction: A possible prophylaxis of acute acalculous cholecystokinin in intensive care patients. Digestion 1995;56:389–394.
Ertan A, Brooks FP, Ostrow JD, et al. Effect of jejunal amino acid perfusion and exogenous cholecystokinin on the exocrine pancreatic and biliary secretions in man. Gastroenterology 1971;61:686–692.
Owyang C, Louie DS, Tatum D. Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. J Clin Invest 1986;77:2042–2047.
Watanabe S, Shiratori K, Takeuchi T, et al. Release of cholecystokinin and exocrine pancreatic secretion in response to an elemental diet in human subjects. Dig Dis Sci 1986;31:919–924.
Hopman WPM, Dejong AJL, Rosenbusch G, et al. Elemental diet stimulated gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide in man. Dig Dis Sci 1987;32: 45–49.
Nealon WH, Upp JR, Alexander RW, et al. Intravenous amino acids stimulate human gallbladder emptying and hormone release. Am J Physiol 1990;259:G173-G178.
Vagenas KF, Michail C, Vasilakos A, et al. Gallbladder contraction after administration of intravenous amino acids and long-chain triacylglycerols in humans. Nutrition 1991;7:347–349.
De Boer SY, Masclee AAM, Lam WF, et al. Effect of intravenous glucose on gallbladder contraction and CCK secretion. Dig Dis Sci 1994;39:268–274.
Everson G, Braverman TDZ, Johnson ML, et al. A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 1980;79:40–46.
Tachibana I, Watanabe N, Shirohara H, et al. Effects of tetraprenylacetone on pancreatic exocrine secretion and acute pancreatitis in two experimental models in rats. Int J Pancreatol 1995;17:147–154.
Kanayama S, Himeno S, Higashino Y, et al. Plasma cholecystokinin-octapeptide like immunoreactivity in patients with hepatic cirrhosis. Life Sci 1987;41:1915–1920.
Konturek SJ, Tasler J, Cieszkowski M, et al. Intravenous amino acids and fat stimulate pancreatic secretion. Am J Physiol 1979;236:E678-E684.
Isenberg JI, Maxwell V. Intravenous infusion of amino acids stimulates gastric acids secretion in man. N Engl J Med 1978; 298:27–29.
Niederau C, Sonnenberg A, Erckenbrecht J. Effects of intravenous infusion of amino acids, fat, or glucose on unstimulated pancreatic secretion in healthy humans. Dig Dis Sci 1985;30:445–455.
Variyam EP, Fuller RK, Brown FM, et al. Effect of parenteral amino acids on human pancreatic exocrine secretion. Dig Dis Sci 1985;30:541–546.
Wiener I, Inoue K, Fagan CJ, et al. Release of cholecystokinin in man: Correlation of blood levels with gallbladder contraction. Ann Surg 1981;194:321–327.
Masclee AAM, Hopman WPM, Corstens FHM, et al. Simultaneous measurement of gallbladder emptying with cholescintigraphy and ultrasonography during infusion of physiologic doses of cholecystokinin: A comparison. Radiology 1989;173:407–410.
Niederau C, Heintges T, Rovati L, et al. Effects of loxiglumide on gallbladder emptying in healthy volunteers. Gastroenterology 1989;97:1331–1336.
Glenn F, Becker CG. Acute acalculous cholecystitis: An increasing entity. Ann Surg 1982;195:131–136.
Savoca PE, Longo WE, Pasternak P, et al. Does visceral ischemia play a role in the pathogenesis of acute acalculous cholecystitis? J Clin Gastroenterol 1990;12:33–36.
Davidsen D, Jorgensen J. Gallbladder emptying with ceruletide in oral cholecystography. Acta Radiol Diag 1981;22:165–169.
Corazziari E, De Masi E, Gatti V, et al. Caerulein and sphincter of Oddi pressure activity. Ital J Gastroenterol 1982;14:239–241.
Soergel KH. Medical treatment of acute pancreatitis. What is the evidence? Gastroenterology 1978;74:620–628.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shirohara, H., Tabaru, A. & Otsuki, M. Effects of intravenous infusion of amino acids on cholecystokinin release and gallbladder contraction in humans. J Gastroenterol 31, 572–577 (1996). https://doi.org/10.1007/BF02355059
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02355059